VACCINATION UPTAKE IN A COHORT OF PATIENTS ON BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (BDMARDS) AT A MELBOURNE PUBLIC HOSPITAL

被引：0

作者：

Pourhadi, Hedayat ^{[1
]}

Johnson, Amy ^{[1
]}

Foote, Andrew ^{[1
]}

机构：

[1] Northern Hlth, Epping, NSW, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2023年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

ARA-P113

引用

页码：51 / 52

页数：2

共 50 条

[31] Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers
Shimada, Hiromi
Kameda, Tomohiro
Kanenishi, Kenji
Miyatake, Nobuyuki
Nakashima, Shusaku
Wakiya, Risa
Kato, Mikiya
Miyagi, Taichi
Mansour, Mai Mahmoud Fahmy
Hata, Toshiyuki
Kadowaki, Norimitsu
Dobashi, Hiroaki
CLINICAL RHEUMATOLOGY, 2019, 38 (05) : 1453 - 1458
[32] EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS STRATIFIED BY NUMBER OF PRIOR BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
Mease, P. J.
Lertratanakul, A.
Strober, B.
Tsuji, S.
Richette, P.
Lovan, C.
Feng, D.
Anderson, J.
Van den Bosch, F.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 788 - 789
[33] Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers
Hiromi Shimada
Tomohiro Kameda
Kenji Kanenishi
Nobuyuki Miyatake
Shusaku Nakashima
Risa Wakiya
Mikiya Kato
Taichi Miyagi
Mai Mahmoud Fahmy Mansour
Toshiyuki Hata
Norimitsu Kadowaki
Hiroaki Dobashi
Clinical Rheumatology, 2019, 38 : 1453 - 1458
[34] REAL-WORLD USAGE OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS IN GERMANY
Anjohrin, S.
Song, J.
Abe, C.
Banefelt, J.
Dun, Rieem A.
Picker, N.
Kromer, D.
Fuchs, A.
Hahn, P.
Welby, S.
VALUE IN HEALTH, 2023, 26 (12) : S300 - S300
[35] Efficacy of Upadacitinib in Patients with Psoriatic Arthritis Stratified by Number of Prior Biologic Disease-modifying Anti-rheumatic Drugs
Mease, Philip
Lertratanakul, Apinya
Strober, Bruce
Tsuji, Shigeyoshi
Richette, Pascal
Lovan, Charlie
Feng, Dai
Anderson, Jaclyn K.
Van den Bosch, Filip
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[36] Methotrexate Use and the Risk for Cardiovascular Disease Among Rheumatoid Patients Initiating Biologic Disease-Modifying Anti-Rheumatic Drugs
Xie, Fenglong
Chen, Lang
Levitan, Emily
Muntner, Paul M.
Curtis, Jeffrey R.
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[37] Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
Michelena, Xabier
Borrell, Helena
Lopez-Corbeto, Mireia
Lopez-Lasanta, Maria
Moreno, Estefania
Pascual-Pastor, Maria
Erra, Alba
Serrat, Mayte
Espartal, Esther
Anton, Susana
Anez, Gustavo Adolfo
Caparros-Ruiz, Raquel
Pluma, Andrea
Trallero-Araguas, Ernesto
Barcelo-Bru, Mireia
Almirall, Miriam
De Agustin, Juan Jose
Llados, Jordi
Julia, Antonio
Marsal, Sara
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (04) : 564 - 570
[38] Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
Agarwal, S.
Zaman, T.
Handa, R.
SINGAPORE MEDICAL JOURNAL, 2009, 50 (07) : 686 - 692
[39] Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs
Soroush Moradi
Maryam Masoumi
Somayeh Mohammadi
Jamshid Vafaeimanesh
Mohaddeseh Mohseni
Hossein Mahdavi
Armin Aryannejad
Internal and Emergency Medicine, 2021, 16 : 919 - 923
[40] Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs
Moradi, Soroush
Masoumi, Maryam
Mohammadi, Somayeh
Vafaeimanesh, Jamshid
Mohseni, Mohaddeseh
Mahdavi, Hossein
Aryannejad, Armin
INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (04) : 919 - 923

← 1 2 3 4 5 →